SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajooni Biotech - Quaterly Results

09 May 2022 Evaluate
The sales for the March 2022 quarter moved up 26.71% to Rs. 205.12 millions as compared to Rs. 161.88 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2022 is Rs. -0.62 millions as compared to Net Profit of Rs. 0.43 millions of corresponding quarter ended March 2021Operating profit for the quarter ended March 2022 rose to 4.41 millions as compared to 3.43 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 205.12 161.88 26.71 740.38 510.39 45.06 740.38 510.39 45.06
Other Income 0.14 0.05 180.00 0.38 0.17 123.53 0.38 0.17 123.53
PBIDT 4.41 3.43 28.57 31.13 16.65 86.97 31.13 16.65 86.97
Interest 1.06 1.51 -29.80 5.40 5.84 -7.53 5.40 5.84 -7.53
PBDT 3.35 1.92 74.48 25.73 10.81 138.02 25.73 10.81 138.02
Depreciation 2.89 1.44 100.69 11.11 5.78 92.21 11.11 5.78 92.21
PBT 0.46 0.48 -4.17 14.62 5.03 190.66 14.62 5.03 190.66
TAX 1.08 0.05 2060.00 4.13 1.31 215.27 4.13 1.31 215.27
Deferred Tax 0.11 -0.09 -222.22 -0.35 -0.19 84.21 -0.35 -0.19 84.21
PAT -0.62 0.43 -244.19 10.49 3.72 181.99 10.49 3.72 181.99
Equity 100.06 100.06 0.00 100.06 100.06 0.00 100.06 100.06 0.00
PBIDTM(%) 2.15 2.12 1.47 4.20 3.26 28.89 4.20 3.26 28.89
Peers
Company Name CMP
Godrej Agrovet 610.05
Avanti Feeds 1468.05
KSE 202.95
Mukka Proteins 24.09
Prima Agro 15.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×